Shelley Shaw
Head of Oncology Marketing Astellas Pharma
Marketing executive with over 25 years of accomplishments favorably impacting: 15 product
launches, BD partnerships, growth of mature brands in challenging markets for biologics as well as small molecule brands. Domestic and international experience include career development roles in China and Japan. Therapeutic areas of expertise: Oncology, Hematology, Immunology, Pulmonology, BioSurgery, Women’s Health and Neuroscience. Demonstrated successes in people management, motivating and leading cross-functional teams, alignment across diverse cultures, managing and developing direct reports, influencing key stakeholders, and consistently delivering favorable results.
Seminars
Wednesday 20th May 2026
Successfully Co-Launching a Novel CDx & Oncology Treatment to Enable Patient Access to Life-Changing Therapies
2:30 pm
- Best practice examples of launching novel CDx and oncology therapies to ensure streamlined market access
- Considering the challenges and priorities of simultaneously commercialising CDx and precision therapies
Tuesday 19th May 2026
Strategically Executing Biomarker-Driven Clinical Trials within Japan to Facilitate CDx Development Chaired by –
Tuesday 19th May 2026
Panel Discussion: Choosing the Right CDx Partner – Lessons from Japan & Beyond
9:30 am
- Key factors determining the success of a CDx partnership
- Challenges and lessons from CDx development in Japan and globally
- What pharma look for in a CDx partner, and what CDx partners want pharma to know
